US EditionPublished • loading... • Updated
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $133.00
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $133.00
Gilead Sciences (NASDAQ:GILD – Free Report) had its price target lifted by HSBC from $110.00 to $133.00 in a research report report published on Wednesday morning,MarketScreener reports. The brokerage currently has a hold rating on the biopharmaceutical company’s stock. A number of other equities research analysts have also weighed in on the stock. Weiss Ratings […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
